Adachi K, Miki Y, Saito R, Hata S, Yamauchi M, Mikami Y, et al. Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosis. Hum Pathol. 2015;46:1685-93 pubmed publisher

Tanaka S, Miki Y, Hashimoto C, Takagi K, Doe Z, Li B, et al. The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma. Mol Cell Endocrinol. 2015;401:56-64 pubmed publisher

Sato N, Takagi K, Suzuki T, Miki Y, Tanaka S, Nagase S, et al. Immunolocalization of corticotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic factor. Int J Gynecol Cancer. 2014;24:1549-57 pubmed publisher

Takagi K, Moriguchi T, Miki Y, Nakamura Y, Watanabe M, Ishida T, et al. GATA4 immunolocalization in breast carcinoma as a potent prognostic predictor. Cancer Sci. 2014;105:600-7 pubmed publisher

Onodera Y, Motohashi H, Takagi K, Miki Y, Shibahara Y, Watanabe M, et al. NRF2 immunolocalization in human breast cancer patients as a prognostic factor. Endocr Relat Cancer. 2014;21:241-52 pubmed publisher

Nakano K, Miki Y, Hata S, Ebata A, Takagi K, McNamara K, et al. Identification of androgen-responsive microRNAs and androgen-related genes in breast cancer. Anticancer Res. 2013;33:4811-9 pubmed

Shibahara Y, Miki Y, Sakurada C, Uchida K, Hata S, McNamara K, et al. Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer. Hum Pathol. 2013;44:2338-45 pubmed publisher

Iwata H, Masuda N, Ohno S, Rai Y, Sato Y, Ohsumi S, et al. A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer. Breast Cancer Res Treat. 2013;139:441-51 pubmed publisher

Shibahara Y, Miki Y, Ishida T, Nakamura Y, Suzuki T, Ohuchi N, et al. Immunohistochemical analysis of aromatase in metastatic lymph nodes of breast cancer. Pathol Int. 2013;63:20-8 pubmed publisher

Takagi K, Miki Y, Shibahara Y, Nakamura Y, Ebata A, Watanabe M, et al. BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patients. Horm Cancer. 2013;4:92-102 pubmed publisher

Takagi K, Miki Y, Onodera Y, Nakamura Y, Ishida T, Watanabe M, et al. Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens. Endocr Relat Cancer. 2012;19:741-50 pubmed publisher

Shibahara Y, Miki Y, Onodera Y, Hata S, Chan M, Yiu C, et al. Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1. J Pathol. 2012;227:357-66 pubmed publisher

Sakurai M, Miki Y, Masuda M, Hata S, Shibahara Y, Hirakawa H, et al. LIN28: a regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer. J Steroid Biochem Mol Biol. 2012;131:101-6 pubmed publisher

Suzuki S, Takagi K, Miki Y, Onodera Y, Akahira J, Ebata A, et al. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor. Cancer Sci. 2012;103:136-43 pubmed publisher

Marquez Garban D, Mah V, Alavi M, Maresh E, Chen H, Bagryanova L, et al. Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids. 2011;76:910-20 pubmed publisher

Stabile L, Dacic S, Land S, Lenzner D, Dhir R, Acquafondata M, et al. Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome. Clin Cancer Res. 2011;17:154-64 pubmed publisher

Oyama M, Nagashima T, Suzuki T, Kozuka Hata H, Yumoto N, Shiraishi Y, et al. Integrated quantitative analysis of the phosphoproteome and transcriptome in tamoxifen-resistant breast cancer. J Biol Chem. 2011;286:818-29 pubmed publisher

Onodera Y, Miki Y, Suzuki T, Takagi K, Akahira J, Sakyu T, et al. Runx2 in human breast carcinoma: its potential roles in cancer progression. Cancer Sci. 2010;101:2670-5 pubmed publisher

Sasaki Y, Miki Y, Hirakawa H, Onodera Y, Takagi K, Akahira J, et al. Immunolocalization of estrogen-producing and metabolizing enzymes in benign breast disease: comparison with normal breast and breast carcinoma. Cancer Sci. 2010;101:2286-92 pubmed publisher

Oka K, Suzuki T, Onodera Y, Miki Y, Takagi K, Nagasaki S, et al. Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation. Int J Cancer. 2011;128:1770-82 pubmed publisher

Takagi K, Miki Y, Nagasaki S, Hirakawa H, Onodera Y, Akahira J, et al. Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment. Endocr Relat Cancer. 2010;17:415-30 pubmed publisher

Mateizel I, Spits C, De Rycke M, Liebaers I, Sermon K. Derivation, culture, and characterization of VUB hESC lines. In Vitro Cell Dev Biol Anim. 2010;46:300-8 pubmed publisher

Abe K, Miki Y, Ono K, Mori M, Kakinuma H, Kou Y, et al. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer. Hum Pathol. 2010;41:190-8 pubmed publisher

Nagasaki S, Suzuki T, Miki Y, Akahira J, Shibata H, Ishida T, et al. Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression. Cancer Sci. 2009;100:639-45 pubmed publisher

Shibuya R, Suzuki T, Miki Y, Yoshida K, Moriya T, Ono K, et al. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast. Endocr Relat Cancer. 2008;15:113-24 pubmed publisher

Dohi O, Hatori M, Suzuki T, Ono K, Hosaka M, Akahira J, et al. Sex steroid receptors expression and hormone-induced cell proliferation in human osteosarcoma. Cancer Sci. 2008;99:518-23 pubmed

Muto M, Onogawa T, Suzuki T, Ishida T, Rikiyama T, Katayose Y, et al. Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma. Cancer Sci. 2007;98:1570-6 pubmed

Suzuki T, Inoue A, Miki Y, Moriya T, Akahira J, Ishida T, et al. Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor. Endocr Relat Cancer. 2007;14:279-92 pubmed

Miki Y, Suzuki T, Tazawa C, Yamaguchi Y, Kitada K, Honma S, et al. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells. Cancer Res. 2007;67:3945-54 pubmed

Suzuki T, Urano T, Miki Y, Moriya T, Akahira J, Ishida T, et al. Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor. Cancer Sci. 2007;98:644-51 pubmed

Suzuki T, Miki Y, Moriya T, Akahira J, Ishida T, Hirakawa H, et al. 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production. Int J Cancer. 2007;120:285-91 pubmed

Miki Y, Clyne C, Suzuki T, Moriya T, Shibuya R, Nakamura Y, et al. Immunolocalization of liver receptor homologue-1 (LRH-1) in human breast carcinoma: possible regulator of insitu steroidogenesis. Cancer Lett. 2006;244:24-33 pubmed

Miki Y, Suzuki T, Kitada K, Yabuki N, Shibuya R, Moriya T, et al. Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. Cancer Res. 2006;66:535-42 pubmed

Ishibashi H, Suzuki T, Suzuki S, Niikawa H, Lu L, Miki Y, et al. Progesterone receptor in non-small cell lung cancer--a potent prognostic factor and possible target for endocrine therapy. Cancer Res. 2005;65:6450-8 pubmed